Skip To Main Content
Co Yi Chen on Muck Rack

Co Yi Chen

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Co Yi

Contact Co Yi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million

|
By Ocumension Therapeutics, H.C. Wainwright, Co Yi Chen
| tdameritrade.com
Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million Today 1:30 AM ET (Thomson Reuters ONE)Print Press Release Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million - NCX 470 therapeutic profile positively received among U.S. eye care professionals in a market survey conducted with a leading, independent research agency - Potential annual global net sales for NCX 470 estimated to reach at least $300 million within 8 years from the...
Open in Who Shared View Duplicates (235) Issue with article?

Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress

|
By Ocumension Therapeutics, H.C. Wainwright, Mont Blanc, Co Yi Chen
| tdameritrade.com
Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress Today 1:30 AM ET (Thomson Reuters ONE)Print Press Release Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress - NCX 470 0.1% showed up to 1.73mmHg greater mean diurnal intraocular pressure (IOP) reduction from baseline than...
Open in Who Shared View Duplicates (175) Issue with article?
See all 2 articles